Evidencia científica
617 artículos revisados por expertos publicados hasta ahora
-
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease.
-
Granulocyte and Monocyte Adsorption Apheresis Therapy Modulates Monocyte-Derived Dendritic Cell Function in Patients With Ulcerative Colitis
CD14+ / CD16 / CD80 / CD83 / CD86 / circulating / dendritic cells / gma / HLA-DR / immunomodulation / MOA / Monocyte / ulcerative colitis /Continúa
-
Leukocytapheresis for the treatment of IBD
-
Leukocytapheresis for the treatment of active pouchitis: a pilot study
-
Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A
Clinical remission / Corticosteroids / cyclosporine A / gma / Infliximab / intensive / Leukocytapheresis / pediatric / Safety / severe / steroid / ulcerative colitis /Continúa
-
Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study
Clinical trial / COMPARISON / efficacy / gma / hyporesponsiveness / Leukocytapheresis / MOA / Safety / T-lymphocytes / ulcerative colitis /Continúa
-
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.
-
Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis
-
Cytapheresis in Inflammatory Bowel Diseases: Current Evidence and Perspectives
-
Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy
-
Partial remission of refractory RA after Adacolumn cytapheresis: a case report
-
Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up
ContáctanosPara solicitar información adicional
Contáctanos